From GWAS to clinical utility in Parkinson's disease

Lancet. 2011 Feb 19;377(9766):613-4. doi: 10.1016/S0140-6736(11)60062-7. Epub 2011 Feb 1.
No abstract available

Publication types

  • Research Support, Non-U.S. Gov't
  • Comment

MeSH terms

  • Genetic Diseases, Inborn / genetics
  • Genetic Predisposition to Disease / genetics*
  • Genetic Privacy / ethics
  • Genetic Testing / ethics
  • Genome-Wide Association Study*
  • Humans
  • Leucine-Rich Repeat Serine-Threonine Protein Kinase-2
  • Parkinson Disease / genetics*
  • Polymorphism, Single Nucleotide / genetics
  • Protein-Serine-Threonine Kinases / genetics
  • Risk Assessment
  • alpha-Synuclein / genetics

Substances

  • SNCA protein, human
  • alpha-Synuclein
  • LRRK2 protein, human
  • Leucine-Rich Repeat Serine-Threonine Protein Kinase-2
  • Protein-Serine-Threonine Kinases